Average Co-Inventor Count = 6.53
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nexgen Biotechnologies, Inc. (7 from 9 patents)
2. Other (6 from 832,843 patents)
3. Inist St Co., Ltd. (2 from 2 patents)
4. University-Industry Cooperation Group of Kyung Hee University (1 from 592 patents)
5. Lee, Sun Kyo (0 patent)
10 patents:
1. 11786450 - Fusion protein comprising heat shock protein 10 and brazzein protein with enhanced anti-oxidation activity and skin cell proliferation effect and anti-wrinkle cosmetic composition comprising the same as effective component
2. 11166898 - Human growth hormone fusion protein with enhanced thermal stability and cosmetic composition for anti-wrinkle and maintaining skin elasticity comprising the same as effective component
3. 10815284 - Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component
4. 10441632 - Anti-wrinkle and anti-aging cosmetic composition comprising green fluorescent protein-human epidermal growth factor fusion protein as effective component
5. 10266817 - Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component
6. 10125181 - Thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation effect and cosmetic composition for anti-wrinkle and maintaining elasticity of skin comprising the same as effective component
7. 9956270 - Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
8. 9919035 - Pharmaceutical composition comprising bee venom-phospholipase A2 (bv-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity
9. 9879060 - SV82 polypeptide, and cosmetic composition for reducing skin wrinkles and maintaining skin elasticity comprising SV82 polypeptide as active ingredient
10. 9526767 - Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity